Qtron Investments’s ResMed RMD Stock Holding History

Qtron Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$562K	Sell	2,884 -418	-13%	-$86.6K	0.08%	306
2026 Q1	$741K	Buy	3,302 +2	+0.1%	+$498	0.1%	257
2025 Q4	$795K	Hold	3,300	–	–	0.1%	230
2025 Q3	$903K	Buy	3,300 +418	+15%	+$114K	0.11%	212
2025 Q2	$744K	Hold	2,882	–	–	0.1%	255
2025 Q1	$645K	Buy	+2,882	New	+$673K	0.1%	261
2024 Q3	–	Sell	-2,292	Closed	-$439K	–	473
2024 Q2	$439K	Sell	2,292 -472	-17%	-$95.8K	0.06%	335
2024 Q1	$547K	Sell	2,764 -476	-15%	-$87.2K	0.08%	326
2023 Q4	$557K	Buy	+3,240	New	+$498K	0.09%	302
2023 Q1	–	Sell	-1,365	Closed	-$284K	–	449
2022 Q4	$284K	Hold	1,365	–	–	0.06%	351
2022 Q3	$298K	Buy	+1,365	New	+$311K	0.07%	333

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qtron Investments's RMD Position: Q2 2026 in Review

Qtron Investments reduced its ResMed (RMD) stake by 13% in Q2 2026, selling an estimated $86.6K and leaving 2,884 shares worth $562K. The position accounts for 0.08% of the portfolio, ranked #306.

Qtron Investments first reported a position in RMD in Q3 2022 and has held it in 11 quarters since. The position peaked at $903K in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Qtron Investments held 2,884 shares of ResMed worth $562K as of Q2 2026.
Qtron Investments sold 418 ResMed shares in Q2 2026, an estimated $86.6K.
ResMed made up 0.08% of Qtron Investments's portfolio in Q2 2026, its #306 holding.
Qtron Investments first reported a position in ResMed in Q3 2022 and has held it in 11 quarters since.
Qtron Investments's ResMed position peaked at $903K in Q3 2025.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.